Anticancer Activity of a Broccoli Derivative, Sulforaphane, in Barrett Adenocarcinoma: Potential Use in Chemoprevention and as Adjuvant in Chemotherapy

INTRODUCTION: The incidence of Barrett esophageal adenocarcinoma (BEAC) has been increasing at an alarming rate in western countries. In this study, we have evaluated the therapeutic potential of sulforaphane (SFN), an antioxidant derived from broccoli, in BEAC. METHODS: BEAC cells were treated with SFN, alone or in combination with chemotherapeutic, paclitaxel, or telomerase-inhibiting agents (MST-312, GRN163L), and live cell number determined at various time points. The effect on drug resistance/chemosensitivity was evaluated by rhodamine efflux assay. Apoptosis was detected by annexin V labeling and Western blot analysis of poly(ADP-ribose) polymerase cleavage. Effects on genes implicated in cell cycle and apoptosis were determined by Western blot analyses. To evaluate the efficacy in vivo, BEAC cells were injected subcutaneously in severe combined immunodeficient mice, and after the appearance of palpable tumors, mice were treated with SFN. RESULTS: SFN induced both time- and dose-dependent decline in cell survival, cell cycle arrest, and apoptosis. The treatment with SFN also suppressed the expression of multidrug resistance protein, reduced drug efflux, and increased anticancer activity of other antiproliferative agents including paclitaxel. A significant reduction in tumor volume was also observed by SFN in a subcutaneous tumor model of BEAC. Anticancer activity could be attributed to the induction of caspase 8 and p21 and down-regulation of hsp90, a molecular chaperon required for activity of several proliferation-associated proteins. CONCLUSIONS: These data indicate that a natural product with antioxidant properties from broccoli has great potential to be used in chemoprevention and treatment of BEAC.

[1]  B. Ramírez-Wong,et al.  HPLC method validation for measurement of sulforaphane level in broccoli by-products. , 2009, Biomedical chromatography : BMC.

[2]  E. Ho,et al.  Multi-targeted prevention of cancer by sulforaphane. , 2008, Cancer letters.

[3]  O. Ogunwobi,et al.  Statins Inhibit Proliferation and Induce Apoptosis in Barrett's Esophageal Adenocarcinoma Cells , 2008, The American Journal of Gastroenterology.

[4]  T. Veenstra,et al.  Covalent Binding to Tubulin by Isothiocyanates , 2006, Journal of Biological Chemistry.

[5]  T. Kubo,et al.  Sulforaphane induces cell cycle arrest and apoptosis in murine osteosarcoma cells in vitro and inhibits tumor growth in vivo. , 2007, Oncology Report.

[6]  H. Gretz,et al.  Sulforaphane induces growth arrest and apoptosis in human ovarian cancer cells , 2007, Acta obstetricia et gynecologica Scandinavica.

[7]  Y. Yoo,et al.  Induction of apoptosis by isothiocyanate sulforaphane in human cervical carcinoma HeLa and hepatocarcinoma HepG2 cells through activation of caspase-3. , 2007, Oncology reports.

[8]  T. Veenstra,et al.  The role of protein binding in induction of apoptosis by phenethyl isothiocyanate and sulforaphane in human non-small lung cancer cells. , 2007, Cancer research.

[9]  Hui Xiao,et al.  Induction of p21 protein protects against sulforaphane-induced mitotic arrest in LNCaP human prostate cancer cell line , 2007, Molecular Cancer Therapeutics.

[10]  Michele D. Sobolewski,et al.  Sulforaphane induces cell type–specific apoptosis in human breast cancer cell lines , 2007, Molecular Cancer Therapeutics.

[11]  Y. Naito,et al.  Interleukin-8 production via protease-activated receptor 2 in human esophageal epithelial cells. , 2007, International Journal of Molecular Medicine.

[12]  G. Kuttan,et al.  Modulation of Cell-Mediated Immune Response in B16F-10 Melanoma-Induced Metastatic Tumor-Bearing C57BL/6 Mice by Sulforaphane , 2007, Immunopharmacology and immunotoxicology.

[13]  S. Orsulic,et al.  Antiproliferative activity of sulforaphane in Akt-overexpressing ovarian cancer cells , 2007, Molecular Cancer Therapeutics.

[14]  Yung-Hyun Choi,et al.  Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis through downregulation of ERK and Akt in lung adenocarcinoma A549 cells. , 2006, Carcinogenesis.

[15]  M. Červinka,et al.  In Vitro Antiproliferative Effects of Sulforaphane on Human Colon Cancer Cell Line SW620. , 2007, Acta medica.

[16]  Yujuan Shan,et al.  Effect of sulforaphane on cell growth, G(0)/G(1) phase cell progression and apoptosis in human bladder cancer T24 cells. , 2006, International journal of oncology.

[17]  A. Kong,et al.  Cancer chemoprevention of intestinal polyposis in ApcMin/+ mice by sulforaphane, a natural product derived from cruciferous vegetable. , 2006, Carcinogenesis.

[18]  S. Wehage,et al.  Protection against UV-light-induced skin carcinogenesis in SKH-1 high-risk mice by sulforaphane-containing broccoli sprout extracts. , 2006, Cancer letters.

[19]  A. Conney,et al.  Inhibition of 7,12-dimethylbenz(a)anthracene-induced skin tumorigenesis in C57BL/6 mice by sulforaphane is mediated by nuclear factor E2-related factor 2. , 2006, Cancer research.

[20]  M. Lichtenberg,et al.  Comparison of growth inhibition profiles and mechanisms of apoptosis induction in human colon cancer cell lines by isothiocyanates and indoles from Brassicaceae. , 2006, Mutation research.

[21]  E. Ho,et al.  Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells. , 2006, Carcinogenesis.

[22]  G. Kuttan,et al.  Augmentation of Natural Killer Cell and Antibody-Dependent Cellular Cytotoxicity in BALB/c Mice by Sulforaphane, a Naturally Occurring Isothiocyanate from Broccoli through Enhanced Production of Cytokines IL-2 and IFN-γ , 2006, Immunopharmacology and immunotoxicology.

[23]  A. Kong,et al.  p53-independent G1 cell cycle arrest of human colon carcinoma cells HT-29 by sulforaphane is associated with induction of p21CIP1 and inhibition of expression of cyclin D1 , 2006, Cancer Chemotherapy and Pharmacology.

[24]  G. Yen,et al.  Effect of sulforaphane on metallothionein expression and induction of apoptosis in human hepatoma HepG2 cells. , 2005, Carcinogenesis.

[25]  Sung-Dae Cho,et al.  Involvement of c-Jun N-terminal Kinase in G2/M Arrest and Caspase-Mediated Apoptosis Induced by Sulforaphane in DU145 Prostate Cancer Cells , 2005, Nutrition and cancer.

[26]  A. Kong,et al.  Suppression of NF-κB and NF-κB-regulated gene expression by sulforaphane and PEITC through IκBα, IKK pathway in human prostate cancer PC-3 cells , 2005, Oncogene.

[27]  J. Jakubikova,et al.  Role of PI3K/Akt and MEK/ERK signaling pathways in sulforaphane- and erucin-induced phase II enzymes and MRP2 transcription, G2/M arrest and cell death in Caco-2 cells. , 2005, Biochemical pharmacology.

[28]  Michael A. Joseph,et al.  Cruciferous Vegetables, Genetic Polymorphisms in Glutathione S-Transferases M1 and T1, and Prostate Cancer Risk , 2004, Nutrition and cancer.

[29]  D. Hedley,et al.  The dietary isothiocyanate sulforaphane targets pathways of apoptosis, cell cycle arrest, and oxidative stress in human pancreatic cancer cells and inhibits tumor growth in severe combined immunodeficient mice. , 2004, Molecular cancer therapeutics.

[30]  P. Karplus,et al.  A Novel Mechanism of Chemoprotection by Sulforaphane , 2004, Cancer Research.

[31]  S. Srivastava,et al.  Sulforaphane-induced G2/M Phase Cell Cycle Arrest Involves Checkpoint Kinase 2-mediated Phosphorylation of Cell Division Cycle 25C* , 2004, Journal of Biological Chemistry.

[32]  J. Freudenheim,et al.  Breast cancer risk in premenopausal women is inversely associated with consumption of broccoli, a source of isothiocyanates, but is not modified by GST genotype. , 2004, The Journal of nutrition.

[33]  A. Kong,et al.  Modulation of AP-1 by Natural Chemopreventive Compounds in Human Colon HT-29 Cancer Cell Line , 2004, Pharmaceutical Research.

[34]  R. Dhir,et al.  Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo. , 2003, Carcinogenesis.

[35]  Longgui Wang,et al.  Targeting cell cycle machinery as a molecular mechanism of sulforaphane in prostate cancer prevention. , 2004, International journal of oncology.

[36]  D. Wakelin,et al.  Upregulation of the oncogene c-myc in Barrett’s adenocarcinoma: induction of c-myc by acidified bile acid in vitro , 2003, Gut.

[37]  T. Kensler,et al.  Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[38]  T. Ahmed,et al.  Sulforaphane and its metabolite mediate growth arrest and apoptosis in human prostate cancer cells. , 2002, International journal of oncology.

[39]  C. Rao,et al.  Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate. , 2000, Carcinogenesis.

[40]  D. Beer,et al.  Indomethacin-induced apoptosis in esophageal adenocarcinoma cells involves upregulation of Bax and translocation of mitochondrial cytochrome C independent of COX-2 expression. , 2000, Neoplasia.

[41]  Pengfei Li,et al.  Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. , 2000, Cancer research.

[42]  Blot Wj,et al.  The changing epidemiology of esophageal cancer. , 1999, Seminars in oncology.

[43]  R. Goldbohm,et al.  Brassica vegetables and cancer prevention. Epidemiology and mechanisms. , 1999, Advances in experimental medicine and biology.

[44]  J. Fraumeni,et al.  Changing patterns in the incidence of esophageal and gastric carcinoma in the United States , 1998, Cancer.

[45]  J. Fahey,et al.  Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[46]  M. Slovak,et al.  PAK-104P, a pyridine analogue, reverses paclitaxel and doxorubicin resistance in cell lines and nude mice bearing xenografts that overexpress the multidrug resistance protein. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[47]  P. Talalay,et al.  Anticarcinogenic activities of organic isothiocyanates: chemistry and mechanisms. , 1994, Cancer research.

[48]  C. Cho,et al.  A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. , 1992, Proceedings of the National Academy of Sciences of the United States of America.